UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treatment of Supine Hypertension in Patients With Sinucleinopathies

American journal of hypertension, 2021-06, Vol.34 (6), p.662-663

2021

Volltextzugriff (PDF)

Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?

Kidney international, 2020-01, Vol.97 (1), p.213-213

2020

Volltextzugriff (PDF)

La filosofía mexicana en la obra de Luis Villoro

Tla-melaua (en línea), 2022-11, Vol.16 (52)

Leon Jimenez, Hector David

2022

Volltextzugriff (PDF)

PostCOVID effect on endothelial function in hypertensive patients: A new research opportunity

The journal of clinical hypertension (Greenwich, Conn.), 2022-02, Vol.24 (2), p.200-203

2022

Volltextzugriff (PDF)

Is the blood pressure variability the great forgotten parameter?

Hypertension research, 2021-07, Vol.44 (7), p.877-878

2021

Volltextzugriff (PDF)

Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease

American journal of physiology. Renal physiology, 2018-11, Vol.315 (5), p.F1406-F1415

2018

Volltextzugriff (PDF)

Basal insulin analogues in people with diabetes and chronic kidney disease

Diabetic medicine, 2022-02, Vol.39 (2), p.e14679-n/a

2022

Volltextzugriff (PDF)

In response to the paper ‘High‐protein diet: A barrier to the nephroprotective effects of sodium‐glucose co‐transporter‐2 inhibitors?’

Diabetes, obesity & metabolism, 2020-09, Vol.22 (9), p.1701-1702

2020

Volltextzugriff (PDF)

In response to Yaribeygi et al. "Sodium‐glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"

Journal of cellular physiology, 2019-07, Vol.234 (7), p.9906-9907

2019

Volltextzugriff (PDF)

Antidiabetic drugs and stroke risk. Current evidence

European journal of internal medicine, 2018-02, Vol.48, p.1-5

2018

Volltextzugriff (PDF)

Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis

Diabetes research and clinical practice, 2019-02, Vol.148, p.10-13

2019

Volltextzugriff (PDF)

Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade?

Current treatment options in neurology, 2019-05, Vol.21 (5), p.22-22, Article 22

2019

Volltextzugriff (PDF)

A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function

Scientific reports, 2019-03, Vol.9 (1), p.5055-5055, Article 5055

2019

Volltextzugriff (PDF)

The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives

Applied sciences, 2021-09, Vol.11 (18), p.8445

2021

Volltextzugriff (PDF)

Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3925

2023

Volltextzugriff (PDF)

Reply to ‘Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes’ by Yoshimoto et al

Journal of investigative medicine, 2018-02, Vol.66 (2), p.e4-5

2018

Volltextzugriff (PDF)

Evaluación del riesgo hemorrágico de la terapia antitrombótica en pacientes con ictus

Clínica e investigación en arteriosclerosis, 2019-11, Vol.31 (6), p.282-288

2019

Volltextzugriff (PDF)

Bleeding risk assessment for stroke patients on antithrombotic therapy

Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis, 2019-11, Vol.31 (6), p.282

2019

Volltextzugriff (PDF)

Bleeding risk assessment for stroke patients on antithrombotic therapy

Clínica e investigación en arteriosclerosis (Internet, English ed.), 2019-11, Vol.31 (6), p.282-288

2019

Volltextzugriff (PDF)

The mechanism of action of sodium–glucose co‐transporter 2 inhibitors is similar to carbonic anhydrase inhibitors

European journal of heart failure, 2018-02, Vol.20 (2), p.409-409

2018

Volltextzugriff (PDF)

Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months

Diabetes research and clinical practice, 2019-12, Vol.158, p.107916, Article 107916

2019

Volltextzugriff (PDF)

Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation

Atención primaria, 2019-12, Vol.51 (10), p.664

2019

Volltextzugriff (PDF)

GLP-1 and the renin–angiotensin–aldosterone system

The lancet. Diabetes & endocrinology, 2019-05, Vol.7 (5), p.337-337

2019

Volltextzugriff (PDF)

VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

Atherosclerosis, 2019-06, Vol.285, p.17-22

2019

Volltextzugriff (PDF)

Digoxin: Does it have a rest at weekends?

Atención primaria, 2018-04, Vol.50 (4), p.257-258

2018

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(60)
Berichte
(1)

Sprache

Englisch
(47)
Spanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Treatment of Supine Hypertension in Patients With Sinucleinopathies

Is the joint use of diuretics and SGLT2 inhibitors beneficial in diabetic kidney disease?

La filosofía mexicana en la obra de Luis Villoro

PostCOVID effect on endothelial function in hypertensive patients: A new research opportunity

Is the blood pressure variability the great forgotten parameter?

Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease

Basal insulin analogues in people with diabetes and chronic kidney disease

In response to the paper ‘High‐protein diet: A barrier to the nephroprotective effects of sodium‐glucose co‐transporter‐2 inhibitors?’

In response to Yaribeygi et al. "Sodium‐glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"

Antidiabetic drugs and stroke risk. Current evidence

Could renin-angiotensin-aldosterone system activation explain the amputations associated with canagliflozin? The nitric oxide hypothesis

Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade?

A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function

The Influence of Diet and Probiotics on the Response of Solid Tumours to Immunotherapy: Present and Future Perspectives

Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes

Reply to ‘Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes’ by Yoshimoto et al

Evaluación del riesgo hemorrágico de la terapia antitrombótica en pacientes con ictus

Bleeding risk assessment for stroke patients on antithrombotic therapy

Bleeding risk assessment for stroke patients on antithrombotic therapy

The mechanism of action of sodium–glucose co‐transporter 2 inhibitors is similar to carbonic anhydrase inhibitors

Real-life experience with Dulaglutide: Analysis of clinical effectiveness to 24 months

Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation

GLP-1 and the renin–angiotensin–aldosterone system

VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

Digoxin: Does it have a rest at weekends?

Suchergebnisse filtern